Skip to content

United Therapeutics UTHR Tyvaso DPI — Inventory reserve

Similar metrics at other companies

Cumberland Pharmaceuticals logo
CPIXVaprisol — Non-current inventories
$1.17M-0.1%
Array Technologies, Inc. logo
ARRYInventory reserve
-$526K-163%
ALT
ALTGProvision For Inventory Reserves
$800K-38.5%
Forum Energy Technologies logo
FETInventory Valuation Reserves, Deduction and Other Reserve Decrease
$8.09M+521%
Syndax Pharmaceuticals logo
SNDXInventory Reserves
$40.75K
Magnachip Semiconductor logo
MXIncrease Decrease In Inventory Reserve
-$321-127%

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$23B+84.1%
P/E17.9×+7.8×
P/S7.3×+3.2×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's tyvaso dpi — inventory reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's tyvaso DPI — inventory reserve?
United Therapeutics (UTHR) reported tyvaso DPI — inventory reserve of $39.2M in Q1 2026.
What does tyvaso DPI — inventory reserve mean?
Represents the valuation adjustment made to inventory for a specific product to account for potential obsolescence, expiration, or lack of marketability. This reserve reflects management's assessment of the risk that current inventory levels may not be fully recoverable through future sales. It is a critical indicator of inventory management quality and product lifecycle health.